New data from two phase 3 studies found that in patients with relapsing forms of multiple sclerosis (MS), the new anti-CD20 monoclonal antibody drug, ublituximab, is associated with significant ...

Opinions expressed by Entrepreneur contributors are their own. In this digital age, competition seems to be more rampant than ever. The attention of customers is scattered due to the many choices they ...